Telix Reports US$204M Q2 Revenue, Up 63% YOY
Filed with ASX · · 6 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Gozellix Receives Permanent HCPCS Code
- Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
- Telix Precision Medicine Announces AlFluor Radiochemistry Platform
- Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
- Telix Investor Day Presentation
Later from Telix Pharmaceuticals
- Telix H1 2025 Results: Investor Webcast Notification
- Historical Financials in USD and H12025 OPEX (Unaudited)
- Telix H1 2025 Appendix 4D and Interim Report
- Telix H1 2025 Results Presentation
- Telix H1 2025 Results Announcement
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals